Simavita Limited
TSX VENTURE : SV

Simavita Limited

February 04, 2014 14:29 ET

Simavita Limited Announces Grant of Stock Options and Changes to Board of Directors

SYDNEY, AUSTRALIA--(Marketwired - Feb. 4, 2014) - Simavita Limited ("Simavita" or the "Company") (TSX VENTURE:SV) today announced the granting of an aggregate total of 6,876,664 stock options to certain of its directors and officers. Each option that was granted vested immediately and is exercisable until December 3, 2016. The exercise prices of the options that were granted are as follows: 1,469,166 of the options have an exercise price of AUD$0.41 each; 2,469,166 of the options have an exercise price of AUD$0.52 each; 1,469,166 of the options have an exercise price of AUD$0.65 each; and 1,469,166 of the options have an exercise price of $0.82 each. The granting of all options is subject to TSX Venture approval.

Simavita also announced today that Maxwell Lloyd-Jones has resigned as Chairman and director of the Company. The board of directors of the Company sincerely thanks Mr. Lloyd-Jones for his contributions to the Company. Simavita is pleased to announce that Peter Cook has been appointed as the Company's new Chairman. As previously announced, Mr. Cook was first elected to the board of directors of the Company at the annual and special meeting of shareholders of the company held on November 20, 2013.

About Simavita

Simavita is a global leader in the area of incontinence management. Simavita has developed and commercialised the world's first instrumented and integrated system of incontinence assessment and management known as SIM™.

Neither TSX Venture Exchange not its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this Release.

Contact Information